//CITY OF HOPE, NATUREWISE ANNOUNCE LICENSE AGREEMENT FOR NEW TARGETED CANCER THERAPY

CITY OF HOPE, NATUREWISE ANNOUNCE LICENSE AGREEMENT FOR NEW TARGETED CANCER THERAPY

NatureWise will commercially develop HDAC8 inhibitors patented by City of Hope, collaborators.

 

City of Hope today announced that it has licensed its HDAC8 inhibitors patent exclusively to NatureWise Biotech & Medicals Corporation, a pharmaceutical company in Taipei, Taiwan.

 

Read more:

https://www.cityofhope.org/news/city-of-hope-naturewise-announce-license-agreement

2018-05-25T18:46:25+00:00 2016 / 09 / 30|Categories: News|Tags: |
error: Content is protected !!